Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2005
DOI: 10.1016/j.jim.2005.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Production and characterization of mouse ureteric bud cell-specific rat hybridoma antibodies utilizing subtractive immunization and high-throughput screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
7
0

Year Published

2009
2009
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…Theoretically, all these antibodies should preferentially react with the surface protein of HL60/DOX cells, because HL60 cells are used in the tolerization step with cyclophosphamide. However, antibodies produced from subtractive immunization strategy are not always specific for immunogen but also toward the tolerogen in some cases, which may due to the incomplete or nonabsolute elimination of tolerogen responsive B cells, as reported in studies by Mernaugh et al . Importantly, this study is not only for demonstrating some cell surface markers but also for identifying the cell surface protein with functional role in cell drug response.…”
Section: Discussionmentioning
confidence: 73%
See 2 more Smart Citations
“…Theoretically, all these antibodies should preferentially react with the surface protein of HL60/DOX cells, because HL60 cells are used in the tolerization step with cyclophosphamide. However, antibodies produced from subtractive immunization strategy are not always specific for immunogen but also toward the tolerogen in some cases, which may due to the incomplete or nonabsolute elimination of tolerogen responsive B cells, as reported in studies by Mernaugh et al . Importantly, this study is not only for demonstrating some cell surface markers but also for identifying the cell surface protein with functional role in cell drug response.…”
Section: Discussionmentioning
confidence: 73%
“…the cell-and antibody-based subtractive immunization coupled with novel proteomic mass spectrometry (MS) sequencing was applied to compare the differentially expressed cell-surface proteins involved in the MDR (9,10). In addition, with the combination of the immunosuppressant cyclophosphamide and the sequential immunization of two cell types with highly similar genetic backgrounds but different phenotypes with respect to MDR potential, this approach is able to generate monoclonal antibodies capable of distinguishing cellsurface proteins that may play a functional role in MDR (11)(12)(13). Especially, the monoclonal antibodies and their immunogens generated by this approach may provide novel clinically relevant reagents and/or tools for cancer immunotherapy and diagnosis, because these antibodies normally are not commercially available (14)(15)(16).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…method has achieved the desired results in the production of mAbs of different cells and proteins in the past decade [6], [7], [8], [9], [19], [20], [21], [22], [23]. First, S.I.…”
Section: Discussionmentioning
confidence: 99%
“…A S.I. strategy was also performed in rats to generate high specific mAbs that preferentially reacted with antigens on ureteric bud, but not adult inner medullary collecting duct cells [20]. Second, S.I.…”
Section: Discussionmentioning
confidence: 99%